Obstructive Hypertrophic Cardiomyopathy: Expert Guidance on Novel Treatment Approaches

In an upcoming Peer Exchange experts in cardiology will discuss novel treatment approaches for obstructive hypertrophic cardiomyopathy.

Related Videos
Reena Mehra, MD: Biomarkers and Endophenotypes for Personalized Patient Care
Reena Mehra, MD: Exploring Endophenotypes for Predicting Clinical Sleep Outcomes
Reena Mehra, MD, MS
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, PA-C
Related Content

Cardiology Case Report: Older Man with Near Syncope

July 5th 2023

Don't Miss a Beat: ESC Heart Failure Association Preview

May 19th 2023

Cardiology Month in Review: June 2023

July 2nd 2023

Don't Miss a Beat: Top Takeaways from NUDGE FLU at ACC 2023

March 5th 2023

SGLT2 Inhibitors Benefit CV Outcomes Across Heart Failure, T2D, CKD Populations

June 21st 2023

New AHA Scientific Statement Reviews Disparities in Peripheral Artery Disease

June 20th 2023

Cardiology Case Report: Older Man with Near Syncope

July 5th 2023

Don't Miss a Beat: ESC Heart Failure Association Preview

May 19th 2023

Cardiology Month in Review: June 2023

July 2nd 2023

Don't Miss a Beat: Top Takeaways from NUDGE FLU at ACC 2023

March 5th 2023

SGLT2 Inhibitors Benefit CV Outcomes Across Heart Failure, T2D, CKD Populations

June 21st 2023

New AHA Scientific Statement Reviews Disparities in Peripheral Artery Disease

June 20th 2023

Cardiology Case Report: Older Man with Near Syncope

July 5th 2023

Don't Miss a Beat: ESC Heart Failure Association Preview

May 19th 2023

Cardiology Month in Review: June 2023

July 2nd 2023

Don't Miss a Beat: Top Takeaways from NUDGE FLU at ACC 2023

March 5th 2023

SGLT2 Inhibitors Benefit CV Outcomes Across Heart Failure, T2D, CKD Populations

June 21st 2023

New AHA Scientific Statement Reviews Disparities in Peripheral Artery Disease

June 20th 2023
© 2023 MJH Life Sciences

All rights reserved.